EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of vagus nerve stimulator during transition to adulthood in patients with treatment‐resistant epilepsy

Jonadab Dos Santos Silva iD, Shaylla Villas Boas iD, Henrique Januzzelli Pires do Prado iD, Daniela Fontes Bezerra iD, Isabella D'Andrea Meira iD

Epileptic Disorders · 2026

DOI: 10.1002/epd2.70133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epileptic Disorders, 2026. Verfasst von Jonadab Dos Santos Silva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Drug Resistant Epilepsy, Outcome Assessment, Health Care. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the efficacy of vagus nerve stimulation (VNS) as an adjunctive treatment in pediatric patients with treatment‐resistant epilepsy during the transition to adolescence.

Methods

We performed a retrospective cohort study of 30 children (ages 2–18 years) with medication‐resistant epilepsy who underwent VNS implantation between January 2019 and January 2023 at a tertiary epilepsy center. Clinical data included demographics, epilepsy etiology and syndrome, age at implantation, seizure frequency and severity (McHugh classification), number of antiseizure medications (ASM), magnet use, and EEG findings. Outcomes were assessed at the last available follow‐up, with a minimum duration of 12 months post‐implantation. Statistical analyses comprised chi‐squared or Fisher's exact tests, Spearman rank correlation, and logistic regression; significance was set at p < 0.05.

Results

At the last follow‐up, 20 of 30 patients (66.7%) achieved ≥50% reduction in seizure frequency, and 73% of patients experienced a significant decrease in seizure severity. Status epilepticus (SE) incidence fell from 67% pre‐VNS to 17% post‐VNS ( p = 0.024). The number of ASMs decreased in 57% of patients. Successful magnet activation strongly predicted responder status (OR 10.8, 95% CI 1.2–95.4; p = 0.024). Among females, 12 of 16 (75%) experienced a transient seizure worsening around menarche. Earlier VNS implantation correlated with better seizure reduction (ρ = −0.43; p = 0.015). EEG improvement—defined as reduced interictal epileptiform activity or background normalization—was observed in 23% of patients, predominantly in males and pre‐menarche females. Significance VNS is an effective adjunctive therapy in pediatric treatment‐resistant epilepsy, yielding substantial reductions in seizure frequency and severity, lowering status epilepticus risk, and simplifying medication regimens. Pubertal status and magnet responsiveness modulate outcomes. Early VNS intervention and proactive management during adolescence may optimize therapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vagus Nerve StimulationDrug Resistant EpilepsyOutcome Assessment, Health CareHumansFemaleAdolescentMaleRetrospective StudiesChildChild, PreschoolTreatment OutcomeElectroencephalography

Stichwörter der Autor:innen

Lennox–Gastaut syndromeadolescenceatonic seizure (drop attack)clonic seizuregeneralized tonic‐clonic seizurepubertyvagus nerve stimulation

Autor:innen und Institutionen

  • Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Epilepsy Center, Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil.
  • Fluminense Federal University, Postgraduate Program in Neurology and Neuroscience, Niterói, Brazil.
  • Department of Epilepsy, Faculdade de Medicina do ABC, São Paulo, Brazil.

ORCID-Profile: Jonadab Dos Santos Silva, Shaylla Villas Boas, Henrique Januzzelli Pires do Prado, Daniela Fontes Bezerra, Isabella D'Andrea Meira

Zitieren

APA

Dos Santos Silva, J., Boas, S. V., do Prado, H. J. P., Bezerra, D. F., & Meira, I. D. (2026). Efficacy of vagus nerve stimulator during transition to adulthood in patients with treatment‐resistant epilepsy. Epileptic Disorders. https://doi.org/10.1002/epd2.70133

Vancouver

Dos Santos Silva J, Boas SV, do Prado HJP, Bezerra DF, Meira ID. Efficacy of vagus nerve stimulator during transition to adulthood in patients with treatment‐resistant epilepsy. Epileptic Disorders. 2026. doi:10.1002/epd2.70133

BibTeX
@article{DosSantosSilva2026,
  author = {Dos Santos Silva, Jonadab and Boas, Shaylla Villas and do Prado, Henrique Januzzelli Pires and Bezerra, Daniela Fontes and Meira, Isabella D'Andrea},
  title = {Efficacy of vagus nerve stimulator during transition to adulthood in patients with treatment‐resistant epilepsy},
  journal = {Epileptic Disorders},
  year = {2026},
  doi = {10.1002/epd2.70133}
}
Kostenlos starten →